Dyshidrosiform Bullous Pemphigoid: A Palmar Variant of a Common Disease

Dyshidrosiform bullous pemphigoid (DBP) is a rare variant of bullous pemphigoid (BP) that mainly affects elderly patients and presents with tense bullae formation on the palms, soles, or both palms and soles. This case report describes an 87-year-old woman who was evaluated in the hospital for a month-long erythematous and pruritic rash on most of her body that eventually manifested into tense blisters on the palms. DBP can pose a challenge to clinicians as it can resemble a variety of different vesicular diseases. Therefore, clinical suspicion, as well as confirmatory testing with direct immunofluorescence (DIF), can aid clinicians in making a diagnosis of DBP. The mainstay of treatment is oral corticosteroids plus an immunosuppressant, but some monoclonal antibodies have shown promising efficacy in the treatment of more refractory cases of DBP. Additional research that focuses on the role of these monoclonal antibodies in the treatment of DBP is needed to determine their therapeutic benefit.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-12-13
DOI
https://doi.org/10.7759/cureus.75639
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dyshidrosiform Bullous Pemphigoid: A Palmar Variant of a Common Disease

Mitchell Brady, Alexa Lum
Cureus
Autoimmune Bullous Skin Diseases
article

Dyshidrosiform Bullous Pemphigoid: A Palmar Variant of a Common Disease

Mitchell Brady, Alexa Lum
article en

Abstract

Dyshidrosiform bullous pemphigoid (DBP) is a rare variant of bullous pemphigoid (BP) that mainly affects elderly patients and presents with tense bullae formation on the palms, soles, or both palms and soles. This case report describes an 87-year-old woman who was evaluated in the hospital for a month-long erythematous and pruritic rash on most of her body that eventually manifested into tense blisters on the palms. DBP can pose a challenge to clinicians as it can resemble a variety of different vesicular diseases. Therefore, clinical suspicion, as well as confirmatory testing with direct immunofluorescence (DIF), can aid clinicians in making a diagnosis of DBP. The mainstay of treatment is oral corticosteroids plus an immunosuppressant, but some monoclonal antibodies have shown promising efficacy in the treatment of more refractory cases of DBP. Additional research that focuses on the role of these monoclonal antibodies in the treatment of DBP is needed to determine their therapeutic benefit.

CureusVol. 16(12)
Botsford Hospital (US), Michigan State University (US)
Zero hunger
Openalex Percentile: Top 62%
Autoimmune Bullous Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dyshidrosiform Bullous Pemphigoid: A Palmar Variant of a Common Disease — Mitchell Brady, Alexa Lum · Cureus (2024) | TGRS Research Map | TGRS